# Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma

> **NCT00934154** · PHASE3 · COMPLETED · sponsor: **Cigdem Sahinbas YILMAZ** · enrollment: 122 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** Melphalan+Prednisolone

## Key facts

- **NCT ID:** NCT00934154
- **Lead sponsor:** Cigdem Sahinbas YILMAZ
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-09
- **Final completion:** 2012-09
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2013-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934154, "Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00934154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*